Roberta A. Jorgensen

8.9k total citations · 2 hit papers
87 papers, 6.5k citations indexed

About

Roberta A. Jorgensen is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Roberta A. Jorgensen has authored 87 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Hepatology, 70 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Roberta A. Jorgensen's work include Liver Diseases and Immunity (78 papers), Liver Disease Diagnosis and Treatment (69 papers) and Liver Disease and Transplantation (40 papers). Roberta A. Jorgensen is often cited by papers focused on Liver Diseases and Immunity (78 papers), Liver Disease Diagnosis and Treatment (69 papers) and Liver Disease and Transplantation (40 papers). Roberta A. Jorgensen collaborates with scholars based in United States, Canada and Belgium. Roberta A. Jorgensen's co-authors include Keith D. Lindor, Paul Angulo, E. Rolland Dickson, Jill C. Keach, Kris V. Kowdley, Russell H. Wiesner, Terry M. Therneau, Edwyn M Harrison, Kenneth P. Batts and Denise M. Harnois and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Roberta A. Jorgensen

84 papers receiving 6.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial

2004 545 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #

2009 478 citations Keith D. Lindor, Kris V. Kowdley et al. Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Roberta A. Jorgensen	4.8k	4.6k	2.6k	1.1k	765	87	6.5k
Pier Maria Battezzati	2.2k 0.5×	2.0k 0.4×	1.4k 0.6×	913 0.8×	699 0.9×	98	4.4k
Piotr Milkiewicz	1.9k 0.4×	1.8k 0.4×	1.5k 0.6×	505 0.5×	750 1.0×	210	3.9k
Marlon F. Levy	3.6k 0.7×	1.9k 0.4×	5.5k 2.1×	401 0.4×	480 0.6×	263	7.7k
Per Stål	3.6k 0.7×	6.0k 1.3×	948 0.4×	206 0.2×	269 0.4×	135	7.7k
Teru Kumagi	1.2k 0.3×	1.6k 0.3×	920 0.4×	296 0.3×	377 0.5×	181	3.2k
Hideki Fujii	1.5k 0.3×	2.5k 0.5×	814 0.3×	223 0.2×	385 0.5×	156	3.9k
Marcin Krawczyk	898 0.2×	1.8k 0.4×	1.1k 0.4×	520 0.5×	418 0.5×	203	3.3k
Chong Il Sohn	714 0.1×	1.5k 0.3×	1.6k 0.6×	1.4k 1.3×	1.7k 2.2×	179	4.5k
Ran Oren	1.6k 0.3×	2.6k 0.6×	1.2k 0.5×	140 0.1×	201 0.3×	82	4.2k
David Van Thiel	1.6k 0.3×	1.3k 0.3×	1.3k 0.5×	201 0.2×	208 0.3×	72	3.3k

Countries citing papers authored by Roberta A. Jorgensen

Since Specialization

Citations

This map shows the geographic impact of Roberta A. Jorgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta A. Jorgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta A. Jorgensen more than expected).

Fields of papers citing papers by Roberta A. Jorgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta A. Jorgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta A. Jorgensen. The network helps show where Roberta A. Jorgensen may publish in the future.

Co-authorship network of co-authors of Roberta A. Jorgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta A. Jorgensen. A scholar is included among the top collaborators of Roberta A. Jorgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta A. Jorgensen. Roberta A. Jorgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabibian, James H., Emma Weeding, Roberta A. Jorgensen, et al.. (2013). Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study. Alimentary Pharmacology & Therapeutics. 37(6). 604–612. 182 indexed citations

Stanich, Peter P., Einar Björnsson, Andrea A. Gossard, et al.. (2011). Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis. Digestive and Liver Disease. 43(4). 309–313. 106 indexed citations

Sinakos, Emmanouil, Ghulam Abbas, Roberta A. Jorgensen, & Keith D. Lindor. (2011). Serum lipids in primary sclerosing cholangitis. Digestive and Liver Disease. 44(1). 44–48. 16 indexed citations

Jorgensen, Roberta A.. (2008). Chronic fatigue: an evolutionary concept analysis. Journal of Advanced Nursing. 63(2). 199–207. 60 indexed citations

Angulo, Paul, Roberta A. Jorgensen, Kris V. Kowdley, & Keith D. Lindor. (2007). Silymarin in the Treatment of Patients with Primary Sclerosing Cholangitis: An Open-Label Pilot Study. Digestive Diseases and Sciences. 53(6). 1716–1720. 28 indexed citations

Talwalkar, Jayant A., Paul Angulo, Jill C. Keach, et al.. (2005). Mycophenolate Mofetil for the Treatment of Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 100(2). 308–312. 45 indexed citations

Jorgensen, Roberta A., et al.. (2003). Treatment With Ursodeoxycholic Acid Is Associated With Weight Gain in Patients With Primary Biliary Cirrhosis. Journal of Clinical Gastroenterology. 37(2). 183–185. 26 indexed citations

Jorgensen, Roberta A.. (2003). Nonalcoholic Fatty Liver Disease. Gastroenterology Nursing. 26(4). 150–154. 95 indexed citations

Jorgensen, Roberta A., Paul Angulo, E. Rolland Dickson, & Keith D. Lindor. (2002). Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. The American Journal of Gastroenterology. 97(10). 2647–2650. 23 indexed citations

10.

Joshi, Supriya, Karen Cauch‐Dudek, Ian R. Wanless, et al.. (2002). Primary biliary cirrhosis with additional features of autoimmune hepatitis: Response to therapy with ursodeoxycholic acid. Hepatology. 35(2). 409–413. 116 indexed citations

11.

Harnois, Denise M., Paul Angulo, Roberta A. Jorgensen, Nicholas F. LaRusso, & Keith D. Lindor. (2001). High-Dose Ursodeoxycholic Acid as a Therapy for Patients With Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 96(5). 1558–1562. 154 indexed citations

12.

Lindor, Keith D., Roberta A. Jorgensen, Robert D. Tiegs, Sundeep Khosla, & E. Rolland Dickson. (2000). Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. Journal of Hepatology. 33(6). 878–882. 60 indexed citations

13.

Angulo, Paul, Roberta A. Jorgensen, Jill C. Keach, et al.. (2000). Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology. 31(2). 318–323. 136 indexed citations

14.

Angulo, Paul, E. Rolland Dickson, Terry M. Therneau, et al.. (1999). Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. Journal of Hepatology. 30(5). 830–835. 98 indexed citations

15.

Angulo, Paul, Roberta A. Jorgensen, Kathleen S. Egan, et al.. (1998). Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. Journal of Hepatology. 29(5). 729–735. 92 indexed citations

16.

Jorgensen, Roberta A., et al.. (1998). Autoimmune Conditions Associated With Primary Biliary Cirrhosis: Response to Ursodeoxycholic Acid Therapy. The American Journal of Gastroenterology. 93(6). 958–961. 31 indexed citations

17.

Lindor, Keith D., Roberta A. Jorgensen, Terry M. Therneau, Michael Malinchoc, & E. Rolland Dickson. (1997). Ursodeoxycholic Acid Delays the Onset of Esophageal Varices in Primary Biliary Cirrhosis. Mayo Clinic Proceedings. 72(12). 1137–1140. 114 indexed citations

18.

Jorgensen, Roberta A., E. Rolland Dickson, Alan F. Hofmann, Steven S. Rossi, & Keith D. Lindor. (1995). Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.. Gut. 36(6). 935–938. 60 indexed citations

19.

Crippin, Jeffrey S., K. Lindor, Roberta A. Jorgensen, et al.. (1992). Hypercholesterolemia and Atherosclerosis in Primary Biliary Cirrhosis: What Is the Risk?. Hepatology. 15(5). 858–862. 112 indexed citations

20.

Gores, Gregory J., Russell H. Wiesner, E. Rolland Dickson, et al.. (1989). Prospective evaluation of esophageal varices in primary biliary cirrhosis: Development, natural history, and influence on survival. Gastroenterology. 96(6). 1552–1559. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact